Total Funding
92
62
Total FundingPost-IPO Equity raised
Growth Score
-3 pts
Heat Score
-24 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
69878
Palisade Bio is a clinical-stage biopharmaceutical company that develops therapies for acute and chronic gastrointestinal complications.
- John Rodenrys: Founder, CTO and EVPPast Role: Leading BioSciences, Inc., Executive VP, CTO
- Robert McRae: Chief Operating OfficerPast Role: Palisade Bio, Senior Vice President, Operations and Strategic Development
About the Company
Palisade Bio is a clinical-stage biopharmaceutical company developing treatments for diseases of unmet medical need. They base these treatments on sound science and therapies with a decades-long history of safe and effective usage. The company's mission is to develop and commercialize novel therapeutics that target diseases resulting from a
loss of gastrointestinal barrier integrity.
The company was founded in 2011 and is headquartered in Carlsbad, California.
